SAN DIEGO, Feb. 6, 2017 /PRNewswire/ -- NuVasive, Inc.
(NASDAQ: NUVA), a leading medical device company focused on
transforming spine surgery with minimally disruptive,
procedurally-integrated solutions, today announced that management
will present at the Leerink Partners 6th Annual
Healthcare Conference at the Lotte New York Palace Hotel in
New York, New York on Wednesday, February 15, 2017 at 11:00 a.m. ET / 8:00 a.m.
PT.
A live webcast of the presentation will be available online from
the Investor Relations page of the Company's website at
www.nuvasive.com. A replay of the presentation will remain
available on the website for 30 days after the applicable live
webcast.
About NuVasive
NuVasive,
Inc. (NASDAQ: NUVA) is a world leader in minimally invasive,
procedurally-integrated spine solutions. From complex spinal
deformity to degenerative spinal conditions, NuVasive is
transforming spine surgery with innovative technologies designed to
deliver reproducible and clinically proven surgical outcomes.
NuVasive's highly differentiated, procedurally-integrated solutions
include access instruments, implantable hardware and software
systems for surgical planning and reconciliation technology that
centers on achieving the global alignment of the spine. With
$811 million in revenues (2015),
NuVasive has an approximate 2,300 person workforce in more than 40
countries around the world. For more information, please visit
www.nuvasive.com.
Forward-Looking
Statements
NuVasive cautions you
that statements included in this news release that are not a
description of historical facts are forward-looking statements that
involve risks, uncertainties, assumptions and other factors which,
if they do not materialize or prove correct, could
cause NuVasive's results to
differ materially from historical results or those expressed or
implied by such forward-looking statements. The potential risks and
uncertainties which contribute to the uncertain nature of these
statements include, among others, risks associated with acceptance
of the Company's surgical products and procedures by spine
surgeons, development and acceptance of new products or product
enhancements, clinical and statistical verification of the benefits
achieved via the use of NuVasive's products
(including the iGA™ platform), the Company's ability to effectually
manage inventory as it continues to release new products, its
ability to recruit and retain management and key personnel, and the
other risks and uncertainties described
in NuVasive's news releases
and periodic filings with the Securities and
Exchange Commission. NuVasive's public filings
with the Securities and Exchange
Commission are available
at www.sec.gov. NuVasive assumes
no obligation to update any forward-looking statement to reflect
events or circumstances arising after the date on which it was
made.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nuvasive-to-present-at-leerink-partners-6th-annual-global-healthcare-conference-2017-300402200.html
SOURCE NuVasive, Inc.